Alaunos Therapeutics, Inc. (TCRT)
NASDAQ·Healthcare·Biotechnology
$2.27
+2.49%
Mkt Cap $8.15M
No analyst coverage available
We don't have analyst ratings or price target data for Alaunos Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.